Literature DB >> 3736578

Mutagenicity of methylisocyanate and its reaction products to cultured mammalian cells.

W J Caspary, B Myhr.   

Abstract

Methylisocyanate (MIC) induced mutagenic responses in the absence of exogenous activation in the mouse lymphoma cell forward mutation assay at concentrations as low as 8-24 microM. MIC produced predominantly small mutant colonies, suggesting the possibility of clastogenic activity. The intermediate hydrolysis product, methylamine, was also mutagenic without exogenous activation but required several hundred-fold higher concentrations (ca. 3 mM). N,N'-Dimethylurea, the final product in the reaction of methylisocyanate and water, was totally refractory in either the presence or absence of S9 for concentrations up to 57 mM (5 mg/ml). The ethyl ester of N-methylcarbamic acid was also tested since it was the only available analogue to the highly reactive N-methylcarbamic acid intermediate. This compound was mutagenic only in the presence of S9 at doses exceeding 5-40 microM, which suggested the possibility that the free acid, produced by enzymatic hydrolysis, is also mutagenic. The mutagenic activity of the ester resulted solely in the production of small mutant colonies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3736578     DOI: 10.1016/0165-7992(86)90049-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  Cytogenetic studies on MIC gas-exposed persons in Bhopal.

Authors:  B C Das
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Results of in vitro and in vivo genetic toxicity tests on methyl isocyanate.

Authors:  M D Shelby; J W Allen; W J Caspary; S Haworth; J Ivett; A Kligerman; C A Luke; J M Mason; B Myhr; R R Tice
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

3.  Oxidative conversion of isothiocyanates to isocyanates by rat liver.

Authors:  M S Lee
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.